| Virological characteristics of the SARS-CoV-2 JN. 1 variant Y Kaku, K Okumura, M Padilla-Blanco, Y Kosugi, K Uriu, AA Hinay, ... The Lancet Infectious Diseases 24 (2), e82, 2024 | 69 | 2024 |
| Transmissibility, infectivity, and immune evasion of the SARS-CoV-2 BA. 2.86 variant K Uriu, J Ito, Y Kosugi, YL Tanaka, Y Mugita, Z Guo, AA Hinay, O Putri, ... The Lancet Infectious Diseases 23 (11), e460-e461, 2023 | 60 | 2023 |
| Virological characteristics of the SARS-CoV-2 BA. 2.86 variant T Tamura, K Mizuma, H Nasser, S Deguchi, M Padilla-Blanco, Y Oda, ... Cell Host & Microbe 32 (2), 170-180. e12, 2024 | 26 | 2024 |
| Antiviral efficacy of the SARS-CoV-2 XBB breakthrough infection sera against omicron subvariants including EG. 5 Y Kaku, Y Kosugi, K Uriu, J Ito, AA Hinay, J Kuramochi, K Sadamasu, ... The Lancet Infectious Diseases 23 (10), e395-e396, 2023 | 25 | 2023 |
| Characteristics of the SARS-CoV-2 omicron HK. 3 variant harbouring the FLip substitution Y Kosugi, A Plianchaisuk, O Putri, K Uriu, Y Kaku, AA Hinay, L Chen, ... The Lancet Microbe, 2024 | 12* | 2024 |
| Virological characteristics of the SARS-CoV-2 Omicron EG. 5.1 variant S Tsujino, S Deguchi, T Nomai, M Padilla-Blanco, A Plianchaisuk, L Wang, ... bioRxiv, 2023.10. 19.563209, 2023 | 10 | 2023 |
| Transmissibility, infectivity, and immune resistance of the SARS-CoV-2 BA. 2.86 variant K Uriu, J Ito, Y Kosugi, YL Tanaka, Y Mugita, Z Guo, AA Hinay Jr, O Putri, ... BioRxiv, 2023.09. 07.556636, 2023 | 6 | 2023 |
| Antiviral humoral immunity against SARS-CoV-2 Omicron subvariants induced by XBB. 1.5 monovalent vaccine in infection-naïve and XBB-infected individuals Y Kosugi, Y Kaku, AA Hinay, Z Guo, K Uriu, M Kihara, F Saito, Y Uwamino, ... The Lancet Infectious Diseases, 2024 | 5 | 2024 |
| Intrinsic Replication Competences of HIV Strains After Zidovudine/Lamivudine/Nevirapine Treatment in the Philippines S Kageyama, A Amolong Hinay Jr, EFO Telan, GMJ Samonte, PSA Leano, ... Journal of the International Association of Providers of AIDS Care (JIAPAC …, 2019 | 5 | 2019 |
| Pro-inflammatory cytokines and interferon-stimulated gene responses induced by seasonal influenza a virus with varying growth capabilities in human lung epithelial cell lines AA Hinay Jr, S Kakee, S Kageyama, A Tsuneki-Tokunaga, WY Perdana, ... Vaccines 10 (9), 1507, 2022 | 4 | 2022 |
| Growth capability of epidemic influenza viruses in Japan since the 2009 H1N1 pandemic A Tsuneki-Tokunaga, K Kanai, A Itagaki, H Tsuchie, T Okada, M Kasagi, ... Archives of Virology 166, 1193-1196, 2021 | 3 | 2021 |
| In vitro inhibition kinetics of crocodylus mindorensis (philippine crocodile) serum against human immunodeficiency virus type i reverse transcriptase AA Hinay, LDC Sarol Adv. Anim. Vet. Sci 6 (5), 213-218, 2018 | 3 | 2018 |
| Local spread of influenza A (H1N1) viruses without a mutation for the maximum duration of an epidemic season in Japan A Tsuneki-Tokunaga, T Kondo, K Kanai, A Itagaki, H Tsuchie, T Okada, ... Archives of Virology, 1-5, 2021 | 2 | 2021 |
| Screening of Mentha cordifolia Opiz (Yerb buena) Buffer Crude Extract for Aspartyl Protease Pepsin Inhibitory Activity LDCS Alfredo A. Hinay Jr. International Journal of Research in Pharmacology and Pharmacotherapeutics 3 …, 2014 | 2* | 2014 |
| Microbial load determination of bacteria on the mobile phones of selected college students AA Hinay, LP Durano, CMTB Enobio, LAT Flores, JAH Reyes Optima 2 (1), 1-1, 2015 | 1 | 2015 |
| In vitro susceptibility of HIV isolates with high growth capability to antiretroviral drugs AA Hinay Jr, K Kanai, A Tsuneki-Tokunaga, M Komatsu, EO Telan, ... International Journal of Molecular Sciences 23 (23), 15380, 2022 | | 2022 |
